Form 4 for LIVN LivaNova PLC
Accepted 2025-04-01 00:00:00 ET · period of report 2025-03-30 · accession 0001639691-25-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-01 | 2025-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | +1,257 | 8,475 | +17% | $0 |
| D | 2025-04-01 | 2025-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | F - Tax | $39.13 | -542 | 7,933 | -6% | -$21.2K |
| DM | 2025-04-01 | 2025-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | -1,257 | 171 | -88% | $0 |
| DM | 2025-04-01 | 2025-03-30 | LIVN | Poletti Franco | Pres, Cardiopulmonary | A - Grant | $0.00 | +33.1K | 14.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-30 | M | A | 1,257 | $0.00 | 8,475 | D | — | — | (F1) Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. |
| 2 | Common | Ordinary Shares | 2025-03-30 | F | D | 542 | $39.13 | 7,933 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 559 | $0.00 | 1,675 | D | — · — to — | 559 Ordinary Shares | (F5) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F7) On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 4 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 325 | $0.00 | 650 | D | — · — to — | 325 Ordinary Shares | (F5) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F6) On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 5 | Derivative | Restricted Stock Units | 2025-03-30 | A | A | 6,388 | $0.00 | 6,388 | D | — · — to — | 6,388 Ordinary Shares | (F5) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement. (F8) On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 6 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 3,194 | $0.00 | 3,194 | D | — · — to — | 3,194 Ordinary Shares | (F9) Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F10) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 7 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 3,194 | $0.00 | 3,194 | D | — · — to — | 3,194 Ordinary Shares | (F9) Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F11) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 8 | Derivative | Performance Stock Units | 2025-03-30 | A | A | 6,388 | $0.00 | 6,388 | D | — · — to — | 6,388 Ordinary Shares | (F9) Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement. (F12) On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. |
| 9 | Derivative | Stock Appreciation Rights | 2025-03-30 | A | A | 13,986 | $0.00 | 13,986 | D | $39.13 · — to 2035-03-30 | 13,986 Ordinary Shares | (F13) On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement. |
| 10 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 201 | $0.00 | 0 | D | — · — to — | 201 Ordinary Shares | (F2) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. (F3) On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. |
| 11 | Derivative | Restricted Stock Units | 2025-03-30 | M | D | 172 | $0.00 | 171 | D | — · — to — | 172 Ordinary Shares | (F2) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement. (F4) On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement. |